Skip to content
MMJ Gazette
  Friday 13 March 2026
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
March 13, 2026Delaware Cannabis Sales Lag Behind Expectations March 10, 2026Cannabis Vapes Top Flower in California Sales Shift March 9, 2026Why Master Growers Top Cannabis Pay March 6, 2026Hemp Industry Braces for THC Ban as Farm Bill Moves Forward March 5, 2026Michigan’s Marijuana Sales Crash 16% in Shocking Turn March 4, 2026Trulieve Slashes 58 Jobs in Florida Restructuring March 3, 2026Tilray’s BrewDog Acquisition Shakes Craft Beer World February 28, 2026States Advance Ryan’s Law for Hospital Cannabis Access February 27, 2026California Cannabis Sales Crash to $3.9 Billion in 2025 February 26, 2026Alabama Medical Marijuana Nears Long-Awaited Launch
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  Cannabis MSO Jushi Cashes In on IRS Tax Credit Amid Processing Delays
CannabisNews

Cannabis MSO Jushi Cashes In on IRS Tax Credit Amid Processing Delays

Lars BeckersLars Beckers—February 24, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Jushi Holdings, a multistate cannabis operator, isn’t waiting around for the IRS to process its Employee Retention Credit (ERC) claims. Instead, the company sold its pending ERC claims to a third party for $5.1 million, securing cash upfront. It’s a move few cannabis businesses have taken advantage of, despite the ERC program offering a lucrative tax break.

A Rare Move in the Cannabis Industry

While many businesses across industries have tapped into the ERC, the cannabis sector has largely overlooked it. The credit, part of the CARES Act, was designed to help businesses that retained employees during the pandemic.

Glen Frost, managing partner of Frost Law, believes many cannabis companies have missed out. “If a business is eligible, it can be a particularly lucrative tax credit,” he told MJBizDaily.

Despite its potential, the window to claim the ERC is closing fast. Companies can still submit claims for the 2021 tax year, but they must do so by April 15.

Why Jushi Sold Its ERC Claims Instead of Waiting

Jushi’s strategy was simple: get the money now rather than wait for the IRS. Trent Woloveck, the company’s chief strategy officer, compared the move to invoice factoring, where businesses sell outstanding invoices for immediate cash.

  • The IRS still owes Jushi about $6 million in ERC claims.
  • By selling the claims to a third party, Jushi received $5.1 million upfront.
  • The company also received $1.3 million from previous IRS refunds.
  • Another $3 million in ERC claims remains outstanding, which Jushi expects the IRS to pay “in due course.”

“IRS has been slow in getting refunds to many different industries for the ERC program,” Woloveck said. “For us to receive cash today, it helps for liquidity on our balance sheet.”

ERC Delays and Fraud Concerns Slow Down Processing

The ERC program, originally part of the CARES Act in March 2020, has undergone several changes. Initially, the IRS processed claims relatively quickly. But that pace has slowed, and some businesses now face a two-year wait for their payments.

Rachel Gillette, a cannabis industry-focused attorney at Holland & Hart, explained that the IRS placed a moratorium on processing claims submitted after Sept. 14, 2023. The reason? A wave of potentially fraudulent submissions.

Many so-called “promoters” filed ERC claims for businesses, often taking a percentage of the refund. However, they didn’t always verify eligibility, leading to concerns about fraudulent claims clogging the system.

More Cannabis Companies Could Benefit—But Time Is Running Out

Jushi’s approach highlights a missed opportunity for many cannabis operators. The ERC was designed to provide financial relief, yet few in the industry have taken full advantage of it.

The IRS still allows claims for the 2021 tax year, but the April 15 deadline is approaching. With processing delays and fraud investigations slowing the system, companies looking to cash in need to act fast—or consider alternative financing options like Jushi.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Could 2025 Be the Year Universities and the Cannabis Industry Finally Join Forces?
Bankruptcy Deal Reached for California Cannabis Company Unrivaled Brands
Related posts
  • Related posts
  • More from author
Cannabis

Delaware Cannabis Sales Lag Behind Expectations

March 13, 20260
Cannabis

Cannabis Vapes Top Flower in California Sales Shift

March 10, 20260
Cannabis

Why Master Growers Top Cannabis Pay

March 9, 20260
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Delaware Cannabis Sales Lag Behind Expectations
  • Cannabis Vapes Top Flower in California Sales Shift
  • Why Master Growers Top Cannabis Pay
  • Hemp Industry Braces for THC Ban as Farm Bill Moves Forward
  • Michigan’s Marijuana Sales Crash 16% in Shocking Turn
  • Trulieve Slashes 58 Jobs in Florida Restructuring
  • Tilray’s BrewDog Acquisition Shakes Craft Beer World
  • States Advance Ryan’s Law for Hospital Cannabis Access
  • California Cannabis Sales Crash to $3.9 Billion in 2025
  • Alabama Medical Marijuana Nears Long-Awaited Launch
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors